HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Consumer Health Brands On Nielsen ‘Breakthrough’ Leaders List Include Lumify As ‘Superstar’

Beauty Brands Love Beauty And Planet And Got2b Also Make BASES’ Innovations List

Executive Summary

“We selected Lumify based on its strong business performance in years one and two, and the success it had in growing a category through premiumization," says Nielsen’s BASES leader, Ben Macedo.

You may also be interested in...



With Preservative-Free Alaway Eye Drops, Bausch Expands OTC Portfolio Of Planned Spin-Off

Approval of Alaway Preservative Free (ketotifen fumarate, 0.035) comes 15 months after FDA submitted a complete response letter to Bausch and the active ingredient developer, Eton Pharmaceuticals. 

Included In Bausch’s Planned Spin-Off, Consumer Brands Account For 3 Spots In Its Top 10 List

Sales of its segment leaders Ocuvite and PreserVision vision health supplements, Lumify OTC eye drops and other consumer lines were down a reported 13% to $321m in the second quarter.

Unilever's Response To 'Tectonic Shifts': Unprecedented M&A, Innovation

CEO Paul Polman took the occasion of Unilever's year-end earnings call to laud the firm’s 11 acquisitions and six new brand launches in 2017, calling Unilever’s portfolio evolution “unprecedented." Recent in-house innovations include Love Beauty and Planet, an environmentally and socially conscious brand aimed at millennials.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

LL1134446

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel